Gyrocardiography- A New Non-invasive Cardiac Measurement Method to Measure Exercise Capacity and Cardiorespiratory Fitness

Last updated: June 29, 2023
Sponsor: Precordior Ltd
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Ergometry

Ergospirometry

Clinical Study ID

NCT05936827
Sport Study
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this study is to produce a solution to measure the cardiorespiratory fitness (CRF), which can be used by commercially available smartphones without extra equipment, add-ons and special know-how.

This observational study with follow-up is to test the feasibility of a new non-invasive cardiac measurement method (gyrocardiography, GCG) in detecting hemodynamic parameters to measure exercise capacity and cardiorespiratory fitness in healthy subjects.

The objective is to produce a solution which can be used to measure the exercise capacity and cardiorespiratory fitness (CRF) of the exercisers, keep-fit athletes and professional athletes using hemodynamic parameters such as:

  • Heart rate and Heart rate variability

  • Cardiac Strength profile

  • Systolic and diastolic phase

  • Breathing frequency

  • VO2max

Participants are either athletes or non-athletic persons. The athletes will perform spiroergometry and non-athletic persons ergometry to measure the CRF expressed as VO2max.

Following parameters will be measured during the (spiro)ergometry:

  • Maximum workload (W)

  • VO2max (ml/kg/min)

  • HRmax

  • Blood lactate

  • Respiratory exchange ratio RER (VO2/VCO2)

The GCG measurements for acquiring the hemodynamic parameters are performed before and after the (spiro)ergometry using smartphone. During a 1- minute GCG measurement, the smart phone is placed on the chest in the middle of the sternum.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: 18-65 years
  • No diagnosed cardiovascular diseases (mild hypertension or hypercholesterolemia arestill allowed)
  • No medication affecting heart rate (i.e. Beta blocker)
  • Signed informed consent Follow-up visit:
  • Belong to non-athletic group
  • Intention to change physical activity habits
  • Willing to participate to the follow-up visit

Exclusion

Exclusion Criteria:

  • Not meeting inclusion criteria
  • Declined to participate
  • Resting RR before the ergometry > 180/110mmHg

Study Design

Total Participants: 200
Treatment Group(s): 2
Primary Treatment: Ergometry
Phase:
Study Start date:
March 01, 2023
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Paavo Nurmi Center

    Turku, 20540
    Finland

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.